Table 2.
Gene | Forward sequence | Reverse sequence |
---|---|---|
rRNA | 5′-CGGCTACCACATCCAAGGAA-3′ | 5′-GCTGGAATTACCGCGGCT-3′ |
Human | ||
CTGF (CCN2) | 5′-CCAATGACAACGCCTCCTG-3′ | 5′-GAGCTTTCTGGCTGCACCA-3′ |
CYR61 (CCN1) | 5′-AGCCTCGCATCCTATACAACC-3′ | 5′-GAGTGCCGCCTTGTGAAAGAA-3′ |
TEAD1 | 5′-ATGCCAACCATTCTTACAGTGAC-3′ | 5′-ACAGTTCCTTTAAGCCACCTTTC-3′ |
TEAD2 | 5′-GCCTCCGAGAGCTATATGATCG-3′ | 5′-TCACTCCGTAGAAGCCACCA-3′ |
TEAD3 | 5′-TGGACCCTCTCAGGACATCAA-3′ | 5′-CCAGGGGCTCATAACTGCTG-3′ |
TEAD4 | 5′-GGACACTACTCTTACCGCATCC-3′ | 5′-TCAAAGACATAGGCAATGCACA-3′ |
YAP (YY1AP1) | 5′-TAGCCCTGCGTAGCCAGTTA-3′ | 5′-TCATGCTTAGTCCACTGTCTGT-3′ |
SURVIVIN (BIRC5) | 5′-AGGACCACCGCATCTCTACAT-3′ | 5′-AAGTCTGGCTCGTTCTCAGTG-3′ |
AXL | 5′-TGTAAAACGACGGCCAGT-3′ | 5′-CAGGAAACAGCTATGACC-3′ |
Mouse | ||
Ctgf (Ccn2) | 5′-GGGCCTCTTCTGCGATTTC-3′ | 5′-ATCCAGGCAAGTGCATTGGTA-3′ |
Cyr61 (Ccn1) | 5′-CTGCGCTAAACAACTCAACGA-3′ | 5′-GCAGATCCCTTTCAGAGCGG-3′ |
Survivin (Birc5) | 5′-GCCACGCATCCCAGCTT-3′ | 5′-TTTCAAAATACCACTGTCTCCTTCTC-3′ |
Axin2 | 5′-CAGATGAACCTGAAGGATACCAAA-3′ | 5′-AGACAACGCTGTTGTTCTCAATG-3′ |
Tbx3 | 5′-CAGGCAGCCTTCAACTGCTT-3′ | 5′-GGACACAGATCTTTGAGGTTGGA-3′ |
Cyclind1 (Ccnd1) | 5′-CGTGGCCTCTAAGATGAAGGA-3′ | 5′-CCTCGGGCCGGATAGAGTAG-3′ |
Yap | 5′-TACTGATGCAGGTACTGCGG-3′ | 5′-TCAGGGATCTCAAAGGAGGAC-3′ |
Tead1 | 5′-AAGCTGAAGGTAACAAGCATGG-3′ | 5′-GCTGACGTAGGCTCAAACCC-3′ |
Tead2 | 5′-GAAGACGAGAACGCGAAAGC-3′ | 5′-GATGAGCTGTGCCGAAGACA-3′ |
Tead3 | 5′-CAACCAGCACAATAGCGTCCA-3′ | 5′-CTGAAAGCTCTGCTCGATGTC-3′ |
Tead4 | 5′-CAACCTGGAACATCCCACGAT-3′ | 5′-GAAAGCCGAGAACTCCAACAT-3′ |
CTGF, connective tissue growth factor; Cyr61, cysteine rich angiogenic inducer 61.